Shorter enrollments could boost participation
An hour-long retirement plan enrolment session with an employee might be doing more harm than good.
- July 16, 2012 September 13, 2019
- 08:08
An hour-long retirement plan enrolment session with an employee might be doing more harm than good.
While biologic drugs can represent a significant percentage of a plan’s drug costs, a Green Shield report says they are not the only thing driving up costs. Of course, plan sponsors need to actively manage biologics as use continues to grow, but they need to look for other places to also control drugs costs.
The Canadian Federation of Independent Businesses (CFIB) say one of the main reasons their members don’t offer a retirement savings vehicle is the cost burden.
The 7% provincial retail sales tax (RST) announced in the Manitoba government’s budget tabled in April 2012 will apply to group life insurance premiums, says a Mercer Communique.
Drug spending in Canada continues to increase and is closely watched by employers. However, a recent report from the Canadian Institute for Health Information’s (CIHI) has revealed some unexpected results.
A stronger economy is good for business, but bad for employee retention.
It’s no secret than most people aren’t saving enough for retirement. But those who are able to save enough may come up short as well, says a new position paper from the Retirement Advisor Council, an association of retirement plan advisors, investment firms and asset managers, and DC plan service providers who advocate for retirement savings issues in the U.S.
Although Canadians have made small improvements to their diets in recent decades, persistently poor eating habits continue to increase their risk of developing a chronic disease later in life, according to a new Conference Board of Canada report. And chronic disease is expected to create a significant burden for benefit plans.
The likelihood of life-altering disability affecting employees could be greater than you—and they—think. And employees aren’t prepared for it.
The Ontario government’s Trillium Drug Program (TDP) can help employers reduce their drug plan costs even more than previously thought.